Cost analysis of the first line antiretroviral therapy in Russian Federation

QR Code

Cost analysis of the first line antiretroviral therapy in Russian Federation

Costs of HIV-infection treatment in Russian Federation are a considerable burden on national resources.Study objective: calculation of one year costs for first line antiretroviral therapy (ART) according to Recommendations (clinical guidelines) of Russian Federal/National Research and Methodology Ce...

Full description

Saved in:

Bibliographic Details
Main Author:	A. V. Rudakova
Format:	Article
Language:	Russian
Published:	Journal Infectology 2014-09-01
Series:	Журнал инфектологии
Subjects:	hiv infection therapy guidelines cost analysis
Online Access:	https://journal.niidi.ru/jofin/article/view/224
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

Durability of first-line antiretroviral treatment in the Russian Federation: retrospective study
by: N. V. Sizova, et al.
Published: (2023-10-01)

Comparison of efficacy and safety of antiretroviral first-line therapy with phosphazideortdf
by: A. V. Kravchenko, et al.
Published: (2018-12-01)

Assessment of efficiency of treatment of patients with acute HIV infection with use in the scheme of antiretroviral therapy elsulfavirin
by: Ya. S. Ulyanova, et al.
Published: (2021-07-01)

Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic
by: Yu. Sh. Gushchina, et al.
Published: (2023-07-01)

Antiretroviral Therapy Complications and Their Correction in HIV-Infected Pregnant Women in the Perioperative Period
by: E. M. Shifman, et al.
Published: (2011-06-01)

The influence of genetic factors on the effectiveness, safety and tolerability of antiretroviral therapy in patients with hiv infection
by: V. G. Kanestri, et al.
Published: (2021-03-01)

Adherence and Cost–Utility Analysis of Antiretroviral Treatment in People Living with HIV in a Specialized Clinic in Mexico City
by: Ivo Heyerdahl-Viau, et al.
Published: (2025-05-01)

THE RESULTS OF THE EFFICACY AND SAFETY OF THE NEW RUSSIAN DRUG 6НР IN THE ANTIRETROVIRAL THERAPY REGIMENS OF HIV-INFECTED PATIENTS
by: A. V. Kravchenko, et al.
Published: (2019-03-01)

The cost-effectiveness of different diagnostic options of TB among HIV-infected patients
by: V. E. Shumlyanskaya, et al.
Published: (2014-12-01)

ANTIRETROVIRAL ROLE IN TUBERCULOSIS PREVENTION AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (RETROSPECTIVE COHORT CLINICAL STUDY)
by: Z. M. Zagdyn, et al.
Published: (2018-04-01)

Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism
by: Ilaria Valentini, et al.
Published: (2025-07-01)

Comparative Cost Analysis of Four Interventions to Prevent HIV Transmission in Bandung, Indonesia
by: Eveline J.M. Verstraaten, et al.
Published: (2017-11-01)

Comparative Cost Analysis of Four Interventions to Prevent HIV Transmission in Bandung, Indonesia
by: Eveline J.M. Verstraaten, et al.
Published: (2017-11-01)

Drug monitoring of antiretroviral drugs in children with perinatal HIV infection
by: A. Yu. Sambyalova, et al.
Published: (2024-07-01)

Evaluation of the Cost-Effectiveness of Vaccination of Children with 5-valent Vaccine against Rotavirus Infection in the Russian Federation
by: Alla V. Rudakova, et al.
Published: (2018-01-01)

The spectrum of opportunistic infections and malignancies among women on antiretroviral therapy in Ethiopia
by: Yimam Getaneh, et al.
Published: (2023-12-01)

The Effectiveness of Antiretroviral Therapy in Mitigating New HIV Infections in Southwest China: An Ecological Study
by: Sun X, et al.
Published: (2025-06-01)

Cost of epilepsy in the Russian Federation
by: A. S. Romanov, et al.
Published: (2024-10-01)

Comparative 10-year atherosclerotic cardiovascular disease risk in Ethiopian HIV patients on first-line versus second-line combined antiretroviral therapy
by: Balew Arega, et al.
Published: (2025-09-01)

Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy
by: Jenna M. Hasson, et al.
Published: (2025-07-01)

Antiviral therapy in chronic hepatitis C (G1) in Russia: cost and effectiveness
by: A. V. Rudakova, et al.
Published: (2015-04-01)

ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA
by: Elamin H. Elbasha, et al.
Published: (2015-09-01)

Regulatory T-lymphocyte subsets in patients with HIV-infection receiving highly active antiretroviral therapy
by: V. A. Chereshnev, et al.
Published: (2019-05-01)

Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2023-01-01)

Psychological problems of HIV-infected patients in preparing to the start of antiretroviral therapy
by: O. V. Koltsova, et al.
Published: (2019-12-01)

HIV Infection and Antiretroviral Therapy Impair Liver Function in People Living with HIV: Systematic Review and Meta-Analysis
by: Kay-Lee E. Strauss, et al.
Published: (2025-06-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES
by: S. V. Malchikova, et al.
Published: (2016-01-01)

DYNAMICS OF CLINICAL LABORATORY PARAMETER IN HIV-INFECTED CHILDREN UNDERGOING DIFFERENT PATTERNS OF INITIAL HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: RANDOMIZED CONTROLLED TRIAL
by: V. B. Denisenko, et al.
Published: (2016-02-01)

HIV-1 and Antiretroviral Therapy Modulate HERV Pol and Syncytin Gene Expression in Mothers and Newborns
by: Anna Pau, et al.
Published: (2025-06-01)

Cost effectiveness analysis of universal varicella vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-10-01)

Сost assessment of HIV prophylaxis of mother to child transmission and family planning program among HIV infected women
by: A. V. Samarina
Published: (2014-09-01)

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
by: A. V. Kravchenko, et al.
Published: (2018-07-01)

Cases inefficient antiretroviral therapy for HIV-1 in children
by: Yu. V. Ostankova, et al.
Published: (2017-06-01)

Regulatory T cell subsets in peripheral blood of HIV-infected patients with discordant response to antiretroviral therapy
by: L. B. Korolevskaya, et al.
Published: (2020-04-01)

HIV and antiretroviral drug resistance
by: N. V. Nemchinova, et al.
Published: (2025-06-01)

COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8
by: Li Ma, et al.
Published: (2025-06-01)

Actual issues of lipid centers’ operation in Russian Federation
by: S. Boytsov, et al.
Published: (2021-02-01)